Cargando…
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models
BACKGROUND: KLRG1 is a lymphocyte co-inhibitory, or immune checkpoint, receptor expressed predominantly on late-differentiated effector and effector memory CD8+ T and NK cells. Targeting of KLRG1 neutralization in murine cancer models has not previously been reported. METHODS: We studied KLRG1 expre...
Autores principales: | Greenberg, Steven A., Kong, Sek Won, Thompson, Evan, Gulla, Stefano V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402715/ https://www.ncbi.nlm.nih.gov/pubmed/30858925 http://dx.doi.org/10.18632/oncotarget.26659 |
Ejemplares similares
-
A Protocol for the Production of KLRG1 Tetramer
por: Terrizzi, Stephanie C., et al.
Publicado: (2010) -
KLRG1 restricts memory T cell antitumor immunity
por: Li, Lei, et al.
Publicado: (2016) -
The Yin and Yang of Targeting KLRG1(+) Tregs and Effector Cells
por: Borys, Samantha M., et al.
Publicado: (2022) -
Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers
por: Tata, Angela, et al.
Publicado: (2021) -
Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy
por: Yang, Xiaodong, et al.
Publicado: (2021)